Seeing Is Believing

Currently out of the existing stock ratings of Lance Wilkes, 55 are a BUY (61.11%), 35 are a HOLD (38.89%).
Analyst Lance Wilkes, currently employed at BERNSTEIN, carries an average stock price target met ratio of 56.97% that have a potential upside of 20.98% achieved within 311 days.
Lance Wilkes’s has documented 176 price targets and ratings displayed on 12 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ELV, Elevance Health at 02-Jul-2026.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for UNH (UNITEDHEALTH GROUP) at 8/4/2025. The price target of $337 was fulfilled within 36 days with a profit of $100.97 (42.78%) receiving and performance score of 11.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Jul-2021
$617
4 years 16 days ago
(22-Jun-2022)
4/6 (66.67%)
$95.47 (18.31%)
149
Buy Since 17-Jun-2022
$550
4 years 21 days ago
(17-Jun-2022)
0/1 (0%)
$95.24 (20.94%)
Buy Since 27-Apr-2017
$596
$113.42 (23.50%)
$574
4 years 1 months 11 days ago
(27-May-2022)
3/5 (60%)
$76.79 (14.79%)
741
Buy Since 19-May-2021
$580
$97.42 (20.19%)
$500
4 years 1 months 13 days ago
(25-May-2022)
3/4 (75%)
$76.52 (15.20%)
177
Buy Since 01-Nov-2018
$625
$142.42 (29.51%)
$510
4 years 2 months 13 days ago
(25-Apr-2022)
5/6 (83.33%)
$119.43 (23.62%)
427
Which stock is Lance Wilkes is most bullish on?
Which stock is Lance Wilkes is most reserved on?
What Year was the first public recommendation made by Lance Wilkes?